Targeting inhibitory pathways in cancer immunotherapy
- 12 May 2010
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 22 (3) , 385-390
- https://doi.org/10.1016/j.coi.2010.04.005
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- CCL2 Blockade Augments Cancer ImmunotherapyCancer Research, 2010
- Immunosenescence: what does it mean to health outcomes in older adults?Published by Elsevier ,2009
- Aging and human CD4+ regulatory T cellsMechanisms of Ageing and Development, 2009
- Fine tuning the immune response through B7‐H3 and B7‐H4Immunological Reviews, 2009
- The complex role of B7 molecules in tumor immunologyTrends in Molecular Medicine, 2008
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionNature Immunology, 2008
- Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virusThe Journal of Experimental Medicine, 2008
- LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systemsJournal of Clinical Investigation, 2007
- Mobilizing the low-avidity T cell repertoire to kill tumorsSeminars in Cancer Biology, 2007
- Checkpoint Blockade in Cancer ImmunotherapyPublished by Elsevier ,2006